The EU drug markets report is the first comprehensive overview of illicit drug markets in the European Union. It covers issues such as production, consumer markets, trafficking, organised crime and policy responses, along with a review of the markets for heroin, cocaine, cannabis, amphetamine, methamphetamine, ecstasy and new psychoactive substances. It concludes with concrete action points for the areas where the current EU response to the drug market and its consequent harms may be improved.\ud
\ud
An essential reference tool for law enforcement professionals, policymakers, the academic community and the general public, the report combines Europol’s strategic and operational understanding of trends and developments in organised crime with the EMCDDA’s ongoing monitoring and analysis of the drug phenomenon in Europe and beyond.\ud
\ud
Table of contents\ud
•	Foreword\ud
•	Introduction\ud
•	Acknowledgements\ud
•	At a glance\ud
•	Chapter 1: Context\ud
•	Chapter 2: Heroin\ud
•	Chapter 3: Cocaine\ud
•	Chapter 4: Cannabis\ud
•	Chapter 5: Amphetamine\ud
•	Chapter 6: Methamphetamine\ud
•	Chapter 7: Ecstasy\ud
•	Chapter 8: New psychoactive substances\ud
•	Chapter 9: Issues in focus\ud
•	Chapter 10: Conclusions and recommendations\ud
•	References\ud
•	Abbreviation